Quarterly Result

Concord Biotech Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln)

BSE Code: 543960

ISIN Demat: INE338H01029

Book Value(₹): 193.06

NSE Symbol: CONCORDBIO

Div & Yield(%): 0.60

Market Cap(₹ Cr): 13,062.90

P/E(TTM): 54.22

EPS(TTM): 23.03

Face Value(₹): 1.00

Particulars Mar 2026 (₹ Cr) Dec 2025 (₹ Cr) Sep 2025 (₹ Cr)
Gross Sales 325.89 278.13 247.06
Excise Duty 0.00 0.00 0.00
Net Sales 325.89 278.13 247.06
Other Operating Income 0.00 0.00 0.00
Other Income 15.54 10.08 13.43
Total Income 341.43 288.22 260.49
Total Expenditure 203.51 179.19 156.52
PBIDT 137.92 109.03 103.97
Interest 0.06 0.06 0.06
PBDT 137.86 108.97 103.91
Depreciation 19.49 18.67 18.39
Tax 28.65 21.57 22.00
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -0.29 0.95 0.63
Reported Profit After Tax 90.02 67.78 62.90
Extra-ordinary Items 0.00 -2.46 0.00
Adjusted Profit After Extra-ordinary item 90.02 70.24 62.90
EPS (Unit Curr.) 8.60 6.48 6.01
EPS (Adj) (Unit Curr.) 8.60 6.48 6.01
Calculated EPS (Unit Curr.) 8.61 6.48 6.01
Calculated EPS (Adj) (Unit Curr.) 8.61 6.48 6.01
Calculated EPS (Ann.) (Unit Curr.) 34.42 25.92 24.05
Calculated EPS (Adj) (Ann.) (Unit Curr.) 34.42 25.92 24.05
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 10.46 10.46 10.46
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 42.32 39.20 42.08
PBDTM(%) 42.30 39.18 42.06
PATM(%) 27.62 24.37 25.46
Attention Investor :
Prevent Unauthorised Transactions in your Trading / Demat account --> Update your Mobile Number with your Depository Participant